TOPK
TOPK (T-lymphokine-activated killer cell–originated protein kinase, also known as PBK or PDZ-binding kinase) is a Ser/Thr protein kinase that is highly expressed in many types of human cancer, including breast and lung cancers. TOPK is included in the “consensus stemness ranking signature” gene list that is up-regulated in cancer stem cell-enriched tumors and is associated with poor prognosis in multiple types of cancer.
TOPK/PBK is an oncogenic kinase upregulated in most human cancers. TOPK is important for mitotic cell division and that phosphorylation by Cdk1 is needed for its activation.
TOPK, a member of the MEK3/6-related MAPKK family, is expressed in a wide range of proliferating cells and tissues, including cancer cells and testis. TOPK negatively regulates the activity of p38α by phosphorylating the p38α-specific phosphatase MKP1 and enhancing the stability of MKP1. The MAPK phosphatase MKP1, an archetypal member of the MKP family, plays a pivotal role in the deactivation of p38 through a dephosphorylation reaction.
Targets for TOPK
Products for TOPK
- Cat.No. Product Name Information
-
GC32181
Cefradine (Cephradine)
SQ 11,436
Cefradine (Cephradine) (Cefradine) is a broad-spectrum and orally active cephalosporin. -
GC12201
HI TOPK 032
T-LAK-cell-originated protein kinase (TOPK) inhibitor
-
GC60929
Ilaprazole sodium
Ilaprazole (IY-81149) sodium is an orally active proton pump inhibitor.
-
GC71719
Ilaprazole sodium hydrate
Ilaprazole (IY-81149) sodium hydrate is an orally active proton pump inhibitor.
-
GC12304
OTS514
TOPK inhibitor,highly potent
-
GC16511
OTS964
OTS964 is an orally active, high affinity and selective TOPK (T-lymphokine-activated killer cell-originated protein kinase) inhibitor with an IC50 of 28 nM. OTS964 is also a potent inhibitor of the cyclin-dependent kinase CDK11, which binds to CDK11B with a Kd of 40 nM.